SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-16-718981
Filing Date
2016-09-26
Accepted
2016-09-26 06:12:03
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d261925dsc14d9.htm SC 14D9 752761
2 EX-99.(A)(17) d261925dex99a17.htm EX-99.(A)(17) 5444
3 GRAPHIC g261925g25d58.jpg GRAPHIC 26452
4 GRAPHIC g261925g76y03.jpg GRAPHIC 33438
5 GRAPHIC g261925g87o99.jpg GRAPHIC 21492
  Complete submission text file 0001193125-16-718981.txt   872917
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filed by) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Subject) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-60719 | Film No.: 161901142
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences